Back to Search
JESSICA LEONARD, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1982921672IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD155787(OR)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
MD155787(OR)
Education
NORTHEASTERN OHIO UNIVERSITY COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Reaching to multiple targets when standing: the spatial organization of feedforward postural adjustments.
PMID 19211658·J Neurophysiol·2009
8-other
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
PMID 18567989·Clin Adv Hematol Oncol·2008
6-review
Identification of a candidate gene for the wheat endopeptidase Ep-D1 locus and two other STS markers linked to the eyespot resistance gene Pch1.
PMID 17952400·Theor Appl Genet·2008
4-observational
HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.
PMID 18996348·Cell Host Microbe·2008
8-other
Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
PMID 17452064·Eur J Med Chem·2008
8-other
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
PMID 18349031·Ann Oncol·2008
8-other
Targeted treatment and new agents in diffuse large B-cell lymphoma.
PMID 18760704·Semin Hematol·2008
6-review
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.
PMID 18853418·Cancer·2008
3-trial
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies.
PMID 17530024·Oncogene·2007
6-review
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
PMID 17947483·Clin Cancer Res·2007
3-trial
Self-assembly of chiral luminescent lanthanide coordination bundles.
PMID 17696537·J Am Chem Soc·2007
8-other
Megafaunal extinctions and the disappearance of a specialized wolf ecomorph.
PMID 17583509·Curr Biol·2007
7-preclinical
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.
PMID 17470451·Ann Oncol·2007
3-trial
pH driven self-assembly of a ternary lanthanide luminescence complex: the sensing of anions using a beta-diketonate-Eu(III) displacement assay.
PMID 17180222·Chem Commun (Camb)·2007
8-other
Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
PMID 17252611·Biotechnol Bioeng·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD, OHSU
PORTLAND, OR 97239 - Phone
- (503) 494-8211
Quick Facts
- NPI
- 1982921672
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile